ESR1 and breast cancer: Moreover, all the major BC subtypes have been represented since HER2-positive (i.e., BT474 and SKBR3), triple-negative (i.e., MDA-MB 231), and estrogen receptor positive (i.e., MCF-7) cell lines have been employed.